These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9305413)

  • 1. Anxiogenic action of caffeine: an experimental study in rats.
    Bhattacharya SK; Satyan KS; Chakrabarti A
    J Psychopharmacol; 1997; 11(3):219-24. PubMed ID: 9305413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiogenic activity of intraventricularly administered bradykinin in rats.
    Bhattacharya SK; Mohan Rao PJ; Sen AP
    J Psychopharmacol; 1995 Jan; 9(4):348-54. PubMed ID: 22298401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain-dependent effects of acute caffeine on anxiety-related behavior in PVG/c, Long-Evans and Wistar rats.
    Hughes RN; Hancock NJ
    Pharmacol Biochem Behav; 2016 Jan; 140():51-61. PubMed ID: 26577750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute caffeine on anxiety-related behavior in rats chronically exposed to the drug, with some evidence of possible withdrawal-reversal.
    Hughes RN; Hancock NJ
    Behav Brain Res; 2017 Mar; 321():87-98. PubMed ID: 28043898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L; Güven O
    Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of caffeine and yohimbine in animal tests of anxiety.
    Baldwin HA; Johnston AL; File SE
    Eur J Pharmacol; 1989 Jan; 159(2):211-5. PubMed ID: 2707309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
    Jones N; Duxon MS; King SM
    Psychopharmacology (Berl); 2002 May; 161(3):314-23. PubMed ID: 12021835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiogenic activity of centrally administered scorpion (Mesobuthus tamulus) venom in rats.
    Bhattacharya SK
    Toxicon; 1995 Nov; 33(11):1491-9. PubMed ID: 8744988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons.
    Vila-Luna S; Cabrera-Isidoro S; Vila-Luna L; Juárez-Díaz I; Bata-García JL; Alvarez-Cervera FJ; Zapata-Vázquez RE; Arankowsky-Sandoval G; Heredia-López F; Flores G; Góngora-Alfaro JL
    Neuroscience; 2012 Jan; 202():384-95. PubMed ID: 22155266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiogenic activity of quinine--an experimental study in rodents.
    Bhattacharya SK; Mitra SK
    Indian J Exp Biol; 1992 Jan; 30(1):33-7. PubMed ID: 1506013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the central melanocortin system in the effects of caffeine on anxiety-like behavior in mice.
    Bhorkar AA; Dandekar MP; Nakhate KT; Subhedar NK; Kokare DM
    Life Sci; 2014 Jan; 95(2):72-80. PubMed ID: 24361398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic activity of Indian Hypericum perforatum Linn: an experimental study.
    Kumar V; Jaiswal AK; Singh PN; Bhattacharya SK
    Indian J Exp Biol; 2000 Jan; 38(1):36-41. PubMed ID: 11233082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites.
    Johnston AL; File SE
    Neuropharmacology; 1989 Jan; 28(1):83-8. PubMed ID: 2538770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of caffeine on behavior and thermoregulation in a chronic unpredictable stress model of depression in rats.
    Pechlivanova D; Tchekalarova J; Nikolov R; Yakimova K
    Behav Brain Res; 2010 Jun; 209(2):205-11. PubMed ID: 20122970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination.
    Garcia AM; Cardenas FP; Morato S
    Behav Brain Res; 2011 Feb; 217(1):171-7. PubMed ID: 20933019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze.
    Rogerio R; Takahashi RN
    Pharmacol Biochem Behav; 1992 Oct; 43(2):631-3. PubMed ID: 1438502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrous cycle modulates the anxiogenic effects of caffeine in the elevated plus maze and light/dark box in female rats.
    Guillén-Ruiz G; Cueto-Escobedo J; Hernández-López F; Rivera-Aburto LE; Herrera-Huerta EV; Rodríguez-Landa JF
    Behav Brain Res; 2021 Sep; 413():113469. PubMed ID: 34280462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiogenic potential of ciprofloxacin and norfloxacin in rats.
    Sen S; Jaiswal AK; Yanpallewar S; Acharya SB
    Singapore Med J; 2007 Nov; 48(11):1028-32. PubMed ID: 17975693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents.
    Braun AA; Skelton MR; Vorhees CV; Williams MT
    Pharmacol Biochem Behav; 2011 Jan; 97(3):406-15. PubMed ID: 20869983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational model for exploratory activity of rats with different anxiety levels in elevated plus-maze.
    Costa AA; Morato S; Roque AC; Tinós R
    J Neurosci Methods; 2014 Oct; 236():44-50. PubMed ID: 25128721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.